Ensatinib in alK-positive Patients Undergoing Initial Treatment for Advanced Non-small Cell Lung Cancer
Clinical trial NCT05132218 · UNKNOWN
Trial details
- NCT number
- NCT05132218
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2021-10-19
- Primary completion
- 2022-10-30
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.